Multiple Sclerosis & Immune Disorders

Filter Your Results

 

News

 

Corrona Partners with National MS Society on Registry to Assess Safety and Efficacy of Therapies

Friday, October 20, 2017—Corrona, LLC and the National Multiple Sclerosis Society will collaborate on the launch of the Corrona Multiple Sclerosis (MS) Registry to study the comparative safety and eff…

The RNA Blood Test for Multiple Sclerosis: A New Tool for Early Disease Identification

Charles “Chase” F. Spurlock, III, PhD and Thomas M. Aune, PhD

October 2017— The process by which hereditary information passes from one generation to the next remains one

Clarifying the Role of Vitamin D in Multiple Sclerosis Risk and Prevention

With Kassandra Munger, ScD

October 2017—Recent findings reinforce the link between vitamin D levels and risk of multiple sclerosis.

FDA Greenlights Two Generic Glatiramer Acetate Formulations for Relapsing MS

Wednesday, October 04, 2017—The FDA approved Mylan’s generic versions of glatiramer acetate, including a three-times weekly 40mg/mL formulation of glatiramer acetate and a once-…

Vitamin D Levels Tied to Risk of MS

Thursday, September 14, 2017—Examining vitamin D levels in the blood may help predict whether a person is at risk of developing multiple sclerosis (MS), according to a large new study published Neurology&…

Rising Drug Prices and the Cost of Care: What Can Physicians Do?

Dennis Bourdette, MD

September 2017—The multiple sclerosis drug market offers a snapshot of a growing problem. Physicians should speak out on behalf of the specialty and their patients.

Project ALS and Amylyx Team Up to Test Phase 2 Compound

Thursday, September 07, 2017—Project ALS and Amylyx Pharmaceuticals are collaborating to undertake pre-clinical studies to advance the understanding of Amylyx's oral compound AMX0035 for the treatment…

CLARITY Extension: Annual Short-Course Therapy with Investigational Oral Agent Effective in Relapsing MS

Tuesday, September 05, 2017—New results suggest that patients with relapsing multiple sclerosis (MS) treated with two annual short courses of the investigational cladribine tablets (EMD Serono) may have …

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC